Inpatient costs associated with alcohol-associated liver disease (ALD) increased from 2016 to 2019, according to a study in ...

The first oral GLP-1 weight-loss pill, which contains semaglutide, became available nationwide Monday, January 5.

Delayed remission with advanced therapies in IBD is not associated with worse 1-year clinical or endoscopic outcomes.

Researchers evaluated whether pregnancy complications, early childhood characteristics, and tobacco-related exposures were ...

The study findings support the current guideline recommendations to discontinue 5-ASA among patients with UC escalated to advanced therapy. Continuation of 5-aminosalicylic acid (5-ASA) use lowers the ...

Nutritional issues such as ARFID are highly prevalent among patients with SSc and can lead to poor outcomes and other ...

This is a syndicated post stub. Gastroenterology Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform ...

Researchers assessed the risk for serious infection during pregnancy and postpartum based on TNF inhibitor exposure among women with chronic inflammatory disease.

The Wyoming Supreme Court blocked 2 abortion ban laws that they found to violate a state constitution amendment.

GLP-1RA therapy significantly reduces the risk for new-onset heart failure in patients with type 2 diabetes or obesity, regardless of weight loss.